Case of large lentigo maligna melanoma of the scalp treated with 5% and 3.75% Imiquimod()()

The paper presents a case of lentigo maligna melanoma of the scalp in an elderly patient treated for the nodular part with surgery and the residual melanoma in situ with 5% Imiquimod and subsequently with 3.75% Imiquimod (each concentration for 4 months, 5 times per week), with complete regression o...

Descripción completa

Detalles Bibliográficos
Autores principales: Rovesti, Miriam, Zucchi, Alfredo, Feliciani, Claudio, Satolli, Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Dermatologia 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441514/
https://www.ncbi.nlm.nih.gov/pubmed/34261602
http://dx.doi.org/10.1016/j.abd.2020.08.025
Descripción
Sumario:The paper presents a case of lentigo maligna melanoma of the scalp in an elderly patient treated for the nodular part with surgery and the residual melanoma in situ with 5% Imiquimod and subsequently with 3.75% Imiquimod (each concentration for 4 months, 5 times per week), with complete regression of the lesion. 3.75% Imiquimod, which is already used for the treatment of actinic keratosis, could be a useful weapon with the same effectiveness and fewer side effects compared to 5% Imiquimod.

Ejemplares similares